CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 5, 2003, Pages 352-359

  Nieri, Paola ^a   Greco, Rosamiria ^a   Adinolfi, Barbara ^a   Breschi, Maria Cristina ^a   Martinotti, Enrica ^a   Nannetti, Carla ^a   Podestà, Adriano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adipocytes; Cannabinoid receptors; Endocannabinoid system; FAAH (fatty acid amide hydrolase); Lipolysis

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE A1 RECEPTOR AGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIMYCIN; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; ENZYME INHIBITOR; FATTY ACID AMIDASE; GLYCEROL; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHENYLISOPROPYLADENOSINE; PROPRANOLOL; PROTEIN KINASE INHIBITOR; AMIDASE; FATTY-ACID AMIDE HYDROLASE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; LIPOLYSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSYCHOPHARMACOLOGY; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; EPIDIDYMIS; GENE EXPRESSION; IN VITRO STUDY; METABOLISM; STEREOISOMERISM; WISTAR RAT;

ADIPOCYTES; AMIDOHYDROLASES; ANIMALS; EPIDIDYMIS; GENE EXPRESSION; GLYCEROL; LIPOLYSIS; MALE; MORPHOLINES; NAPHTHALENES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEREOISOMERISM;

EID: 0344082866     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0831-3     Document Type: Article

References (62)

1. Ameri A, Simmet T (2000) Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn-Schmiedeberg's Arch Pharmacol 361:256-272
2. Breivogel C, Griffin G, Di Marzo V, Martin B (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155-163
3. Chatzipanteli K, Rudolph S, Axelrod L (1992) Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue. Diabetes 41:927-935
4. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P (2001) Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20:7033-7040
5. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
6. Coruzzi G, Adami M, Coppelli G, Frati P, Soldani G (1999) Inhibitory effect of the cannabinoid receptor agonist WIN 55, 212-2 on pentagastrin- induced gastric acid secretion in the anaesthetized rat. Naunyn-Schmiedeberg's Arch Pharmacol 360:715-718
7. 1 receptors in human ileum. Br J Pharmacol 125:1393-1395
8. Cushman S (1970) Structure-function relationships in the adipose cell. Ultrastructure of the isolated adipose cell. J Cell Biol 46:326-341
9. Das S, Paria B, Chakraborty I, Dey S (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 92:4332-4336
10. Di Marzo V (1998) 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392:153-175
11. Di Marzo V (1999) Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. Life Sci 65:645-655
12. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691
13. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-825
14. Egertova M, Giang D, Cravatt B, Elphick M (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc R Soc Lond B Biol Sci 265:2081-2085
15. Fleischmann B, Murray R, Kotlikoff M (1994) Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. Proc Natl Acad Sci USA 91:11914-11918
16. Frühbeck G, Gòmez-Ambrosi J (2001) Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cell Signal 13:827-833
17. Garcia-Barrado M, Sancho C, Iglesias-Osma M, Moratinos J (2001) Effects of verapamil and elgodipine on isoprenaline-induced metabolic responses in rabbits. Eur J Pharmacol 415:105-115
18. 2+ channel current. Am J Physiol 276:H2085-H2093
19. Girouard H, Savard R (1998) The lack of bimodality in the effects of endogenous and exogenous prostaglandins on fat cell lipolysis in rats. Prostaglandins Other Lipid Mediat 56:43-45
20. Giuffrida A, Beltramo M, Piomelli D (2001) Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther 298:7-14
21. Gowri M, Reaven G, Azhar S (1999) Effect of masoprocol on glucose transport and lipolysis by isolated rat adipocytes. Metabolism 48:411-414
22. Guzman M, Sanchez C (1999) Effects of cannabinoids on energy metabolism. Life Sci 65:657-664
23. Hàjos N, Freund TF (2002) Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43:503-510
24. Hàjos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF (2001) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239-3249
25. Haslam RJ, Davidson MM, Desjardins JV (1978) Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J 176:83-95
26. Holland M, John Challiss R, Standen N, Boyle J (1999) Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle. Br J Pharmacol 128:597-604
27. Holm C, Osterlund T, Laurell H, Contreras J (2000) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr 20:365-393
28. Howlett AC, Mukhopadhyay S (2000) Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108:53-70
29. Izzo AA, Mascolo N, Capasso R, Germano MP, De Pasquale R, Capasso F (1999) Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 360:221-223
30. Kathmann M, Weber B, Schlicker E (2001) Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice. Naunyn-Schmiedeberg's Arch Pharmacol 363:50-56
31. 9-Tetrahydrocannabinol: localization in body fat. Science 179:391-393
32. Kunos G, Jàrai Z, Bàtkai S, Goparaju SK, Ishac EJN, Liu J, Wang L, Wagner JA (2000) Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 108:159-168
33. Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42:769-76
34. Liang HX, Belardinelli L, Ozeck MJ, Shryock JC (2002) Tonic activity of the rat adipocyte A1-adenosine receptor. Br J Pharmacol 135:1457-1466
35. Maccarrone M, Fiorucci L, Erba F, Bari M, Finazzi-Agro A, Ascoli F (2000) Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors. FEBS Lett 468:176-180
36. Maier R, Maitre L (1975) Steroidogenic and lipolytic effects of cannabinols in the rat and the rabbit. Biochem Pharmacol 24:1695-1699
37. Malinowska B, Kwolek G, Gothert M (2001) Anandamide and methanandamide induce both vanilloid VR1-and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn-Schmiedeberg's Arch Pharmacol 364:562-569
38. Mater M, Thelen A, Jump D (1999) Arachidonic acid and PGE2 regulation of hepatic lipogenic gene expression. J Lipid Res 40:1045-1052
39. Matsuda L, Lolait S, Brownstein M, Young A, Bonner T (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
40. Munro S, Thomas K, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
41. Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E (2000) Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 361:19-24
42. Niederhoffer N, Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126:457-466
43. Nogueron M, Porgilsson B, Schneider W, Stucky C, Hillard C (2001) Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. J Neurochem 79:371-381
44. Pertwee R (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635-664
45. Pertwee R, Fernando S (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118:2053-2058
46. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21:218-224
47. Ramirez-Ponce M, Acosta J, Bellido J (1990) Electrical activity in white adipose tissue of rat. Rev Esp Fisiol 46:133-138
48. 9- Tetrahydrocannabinol uptake by adipose tissue: preferential accumulation in gonadal fat organs. Gen Pharmacol 10:525-529
49. Rice W, Shannon J, Burton F, Fiedeldey D (1997) Expression of a brain-type cannabinoid receptor (CB1) in alveolar Type II cells in the lung: regulation by hydrocortisone. Eur J Pharmacol 327:227-232
50. Rodbell M (1964) Metabolism of isolated fat cells. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380
51. 9- Tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells. Brain Res 767:64-71
52. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol 54:834-843
53. Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142:278-287
54. Schulte G, Fredholm BB (2002) Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists. Cell Signal 14:109-113
55. Strosberg AD (1997) Structure and function of the beta 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 37:421-50
56. Ueda N, Puffenbarger R, Yamamoto S, Deutsch D (2000) The fatty acid amide hydrolase (FAAH). Chem Phys Lipids 108:107-121
57. Volkow N, Tancredi L, Grant C, Gillespie H, Valentine A, Mullani N, Wang G, Hollister L (1995) Brain glucose metabolism in violent psychiatric patients: a preliminary study. Psychiatry Res 61:243-253
58. Wallmichrath I, Szabo B (2002) Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata. Naunyn-Schmiedeberg's Arch Pharmacol 365:326-334
59. Wieland O (1957) Eine enzymatische Methode zur Bestimmung von Glycerin. Biochem Z 329:313-319
60. 1-tetrahydrocannabinol on Sidman discriminated avoidance behavior in rats. Act Nerv Super (Praha) 16:34-38
61. 2+]i) inhibition of lipolysis in human adipocytes. FASEB J 15:2527-2529
62. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457